These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 25033446

  • 1. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
    Bröker ME, Ijzermans JN, Witjes CD, van Vuuren HJ, de Man RA.
    PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
    [Abstract] [Full Text] [Related]

  • 2. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
    Xu WJ, Guo BL, Han YG, Shi L, Ma WS.
    Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
    [Abstract] [Full Text] [Related]

  • 4. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y.
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY, Li N, Ding HG, Jiang FF.
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G, Dong F, Xu X, Hu A, Hu Y.
    Int J Clin Exp Pathol; 2015 Dec; 8(9):11379-85. PubMed ID: 26617863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.
    J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
    Dai M, Chen X, Liu X, Peng Z, Meng J, Dai S.
    PLoS One; 2015 Dec; 10(10):e0140067. PubMed ID: 26441340
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B, Tian X, Sun J, Meng X.
    Int J Mol Sci; 2013 Dec 02; 14(12):23559-80. PubMed ID: 24317431
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
    Ozkan H, Erdal H, Tutkak H, Karaeren Z, Yakut M, Yüksel O, Köklü S.
    Digestion; 2011 Dec 02; 83(1-2):83-8. PubMed ID: 21042019
    [Abstract] [Full Text] [Related]

  • 15. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
    Wu Y, Ma J, Wang Y, Zhang Y, Hou Y, Zhang C, Sun H, Sun J, Wang Z, Li N.
    Clin Chim Acta; 2018 Jul 02; 482():209-214. PubMed ID: 29630871
    [Abstract] [Full Text] [Related]

  • 16. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, Chan DW, Dowell BL.
    Clin Chem Lab Med; 2011 Apr 02; 49(4):711-8. PubMed ID: 21231906
    [Abstract] [Full Text] [Related]

  • 17. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhou Y, Yin X, Ying J, Zhang B.
    BMC Cancer; 2012 Jan 16; 12():17. PubMed ID: 22244200
    [Abstract] [Full Text] [Related]

  • 18. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L.
    Zhonghua Yi Xue Za Zhi; 2014 Feb 11; 94(5):390-2. PubMed ID: 24746091
    [Abstract] [Full Text] [Related]

  • 19. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
    Liu T, Yao M, Liu S, Wang L, Wang L, Hou J, Ma X, Jia J, Zhao J, Zhuang H, Lu F.
    Oncotarget; 2017 Mar 07; 8(10):16498-16506. PubMed ID: 28157705
    [Abstract] [Full Text] [Related]

  • 20. Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.
    Zhao J, Guo LY, Yang JM, Jia JW.
    Genet Mol Res; 2015 Jun 26; 14(2):7062-7. PubMed ID: 26125916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.